Role of the smooth muscle layer in bladder cancer biology and progression: a systems and experimental approach
Ended Project Grant Awarded Last action
- Award ID
- R21CA266660
- Recipient
-
Weill Medical College Of Cornell University UEI YNT8TCJH8FQ8
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $737,945
Award facts
- Assistance listing
- 93.396 Cancer Biology Research
- Completion date
- Originally
- Place of performance
- New York, USA
Award details come from USAspending.gov.
Description
- Abstract
- Carcinomas are the most common cancers. In tumors arising in hollow organs, two major events during tumor progression are disruption of the basement membrane and invasion of the smooth muscle layer. In bladder cancer, muscle-invasion is associated with lymph node and distant metastases and poor prognosis. Despite extensive interest in the tumor microenvironment, virtually nothing is known about how tumor cells and smooth muscle cells (SMC) interact. Preliminary observations support our central hypothesis that the smooth muscle layer may promote, rather than restrain, tumor progression and that IT can impact on the tumor cell phenotype in a context- dependent manner. We aim to address this significant knowledge GAP through a top-down systems and bottom-up experimental approach. In aim 1, we propose combining high-throughput and spatially-resolved single cell expression profiling with innovative computational analyses of cell-cell interactions in samples from patients with muscle-invasive bladder cancer to identify cellular interactions that modulate tumor cell phenotype at the muscle-invasive front. Special emphasis will be placed on interrogating tumor cell-SMC crosstalk at this interface, although all autocrine and paracrine interactions will be analyzed at a systems level in an unbiased fashion. In aim 2, we propose using CO-culture systems to mechanistically dissect tumor cell-SMC crosstalk, including identifying transcriptomic changes induced by SMC on tumor cells, determining whether this cross- talk is mediated by contact or soluble factors, and identifying candidate pathways that underlie this effect for downstream validation. The amalgamation of these approaches will reveal markers of SMC activation with prognostic and/or predictive value and may lead to the discovery of new therapeutic targets for muscle-invasive bladder cancer. We expect to uncover a yet unexplored role of the tumor microenvironment in bladder cancer phenotypes and progression.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$10,159 | |
| Amendment | $0 | |
| Amendment | $374,052 | |
| Original award | $374,052 |
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| Fundacion Centro Nacional De Investigaciones Oncologicas Carlos III | $138,763 | |
| Fundacion Centro Nacional De Investigaciones Oncologicas Carlos III | $138,763 |
Quick answers
Who received award R21CA266660?
R21CA266660 was awarded to Weill Medical College Of Cornell University by National Cancer Institute (National Institutes of Health) on September 12, 2022.
How much is award R21CA266660 worth?
$737,945 has been obligated on R21CA266660.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award